summary 1. A new method for the measurement of uroporphyrinogen decarboxylase (EC 4.1.1.37) in rat liver homogenates, with 5-carboxyl porphyrinogen as substrate, is described.
Introduction
Several hepatotoxic polychlorinated aromatic hydrocarbons are now known to be porphyrogenic. An experimental hepatic porphyria has been produced in various mammalian and avian species by hexachlorobenzene, polychlorinated biphenyls, tetrachlorodibenzo-p-dioxin and octachlorostyrene. HCBC') poisoning was responsible for an outbreak of porphyria in Turkey in 1956 (Schmid, 1960 ) and exposure to other polychlorinated aromatic hydrocarbons may cause porphyria in workers manufacturing herbicides (Bleiberg, Wallen, Brodkin & Applebaum, 1974) or handling disinfectants (Lynch, Lee & Kushner, 1975) . In man, these compounds are one cause of the syndrome known as porphyria cutanea tarda symptomatica or symptomatic porphyria, a form of hepatic porphyria which is seen most commonly in association with liver damage due to alcohol (Elder, Gray & Nicholson, 1972) . Iron stores are increased in about two-thirds of European patients with symptomatic porphyria (Lundvall, 1971 ; Turnbull, Baker, Vernon-Roberts & Magnus, 1973) . Depletion of storage iron by repeated venesection produces a decrease in the porphyrin excretion, even in those patients with normal stores (Ramsay, Magnus, Turnbull & Baker, 1974) .
Polychlorinated hydrocarbons produce a porphyria which, irrespective of the species in which it occurs, is characterized by overproduction of uroporphyrin and, to a lesser extent, of porphyrins with seven, six and five carboxyl groups, which belong either exclusively (San Martin de Viale, Viale, Nacht & Grinstein, 1970) or, in man, predominantly, to the type 111 isomer series (Chu & Chu, 1967) . In HCB-porphyria in the rat and in symptomatic porphyria the 4-carboxyl porphyrin fractions contain both coproporphyrin and porphyrins of the isocoproporphyrin se.ries (Elder, 1972) . With the exception of coproporphyrin, the porphyrins produced in excess in this type of porphyria all contain acetate substituents. During 71 the course of haem synthesis, uroporphyrinogen decarboxylase (EC 4.1 .1.37) catalyses the sequential decarboxylation of the four acetate substituents of uroporphyrinogen to give coproporphyrinogen, forming, in the process, intermediate porphyrinogens with seven, six and five carboxyl groups (Jackson, Sancovich, Ferramola, Evans, Games, Matlin, Elder & Smith, 1976) . In 1971, Taljaard, Shanley & Joubert reported that uroporphyrinogen decarboxylase activity could not be detected in the livers of rats with iron overload and HCB-porphyria, but that the activity of this enzyme was normal in rats with HCB-porphyria alone. In addition, iron overload altered the porphyrin excretion pattern of the porphyric rats so that it more closely resembled that of symptomatic porphyria. On the other hand, San Martin de Viale, Tomio, Ferramola, Sancovich & Tigier (1972) found a marked decrease in the rate of decarboxylation of both uroporphyrinogen 111 and 7-carboxyl porphyrinogen 111 by liver fractions from rats with HCB-porphyria without apparent iron overload. Kushner & Barbuto (1974) have reported that uroporphyrinogen decarboxylase activity is decreased in symptomatic porphyria.
Current procedures for the assay of uroporphyrinogen decarboxylase, which use uroporphyrinogen I or 111 as substrate, are complicated because porphyrinogens with seven, six and five carboxyl groups (7-, 6-and 5-carboxyl porphyrinogens), as well as the end-product, coproporphyrinogen, may accumulate during the course of the reaction (Tomio, Garcia, San Martin de Viale & Grinstein, 1970; Kushner, Steinmuller & Lee, 1975) . Here we describe a method for the measurement of uroporphyrinogen decarboxylase using 5-carboxyl porphyrinogen as substrate, and its use to investigate the effect of HCB on the activity of uroporphyrinogen decarboxylase in rat liver. This method has the advantage that the rate of only one decarboxylation is measured, thus simplifying the procedure.
A preliminary account of this work has been presented .
Methods

Materials
5-Carboxyl porphyrin 111 [2,4,6,7-(2-carboxyethyl) -5-carboxymethyl-1,3,8-trimethylporphin] was isolated as its methyl ester derivative, from faeces collected from six female Wistar rats during the fifth month on powdered diet 41 B containing HCB (0.3 x, w/w), and stored at -20°C. The faeces (1180 g) were mixed with acetone (3 :1, v/v) and homogenized. The solid material was separated by filtration and suspended in methanol (6 I) containing conc. HzS04 (300 ml). After 40 h in the dark at room temperature, the suspension was filtered and the solid residue washed with methanol. The porphyrin methyl esters in the filtrate and washings were transferred to chloroform (Falk, 1964) , which was evaporated under reduced pressure at 50°C to leave a tar-like residue (about 70 ml) which was extracted repeatedly with ether. The combined extracts were shaken with successive volumes of HCI (7 mol/l) until no porphyrin remained in the ether phase. The residue remaining after ether extraction was suspended in HCI (7 mol/l), left for 16 h at room temperature in the dark and then filtered. The filtrate was added to the porphyrin solution obtained from the ether extracts, which had similarly been left for 16 h, and the pH of the mixture was adjusted to 3 3 with solid NazC03 and acetic acid. The porphyrins were then adsorbed to talc, converted into their methyl esters and fractionated by t.1.c. (Silica gel 60, Merck) in chloroform/ kerosene/methanol (200:100:6, by vol.). The 5-carboxyl porphyrin ester eluted from these plates was further purified by t.1.c. in benzenelbutanone (40: 3, v/v), followed by cyclohexane/acetone (7 : 3, v/v) (Elder, 1972) to yield a porphyrin ester identified as 2,4,6,7-(2-methoxycarbonylethyl)-5-methoxycarbonylmethyl-l,3,8-trimethylporphin (Jackson et al., 1976) and shown, by high-pressure liquid chromatography with the solvent systems described below, to contain less than 0.14% of coproporphyrin tetramethyl ester and no other detectable impurities. Uroporphyrin 111 octamethyl ester was prepared from the feathers of Turacirs sp. (With, 1957) . Synthetic isocoproporphyrin tetramethyl ester was given by Professor G. W. Kenner, Department of Organic Chemistry, Liverpool University.
Porphyrin solutions (1.0-25 mmol/l) were prepared by hydrolysing the methyl esters with HCI (5 mol/l) for 48 h at room temperature in the dark, removing the acid in LYJCIIO over KOH pellets, and dissolving the dry porphyrin in KOH (10 mmol/l) after converting the porphyrin free acid into its ammonium salt by exposure to NH3 vapour. Porphyrinogens were prepared immediately before use by reducing porphyrin solutions with 4% (wlw) sodium-mercury amalgam. Finely powdered amalgam (0.541 g for 0.1 ml of porphyrin solution) was washed three times with water, blotted dry, added to the porphyrin solution and shaken vigorously under N, in dim light until the solution was colourless and showed no red fluorescence in ultraviolet light (Wood's filter).
Treatment of animals
Female Wistar rats (118-150 g body wt.) were divided into two groups. One group (control) were fed with powdered diet 41 B, and the other group (HCB-treated) received the same diet containing 0.3% (w/w) HCB (technical grade, BDH Chemicals Ltd, Poole, Dorset, U.K.). Both groups had free access to food and water. After 4, 7 and 11 weeks, four rats chosen at random from each group were placed in metabolic cages for 24 h for collection of urine. These animals were then killed by decapitation, exsanguinated, and their livers were removed, blotted free of blood and weighed. The times of killing werechosen to coincide with the period of the most rapid increase in porphyrin excretion, which was determined in a preliminary experiment .
Preparation and fractionation of liver homogenates
All procedures were carried out at 4°C. For measurement of uroporphyrinogen decarboxylase, liver was weighed, chopped into small pieces, washed once with sodium chloride solution (0.15 mmol/l; saline) and homogenized in potassium phosphate buffer (50 mmolll), pH 7.0, containing disodium EDTA (0.1 mmol/l), with a motor-driven (800 rev./ min) Teflon pestle (clearance 75 pm) in a glass mortar to give a 20% (wlv) homogenate. Enzyme assays were carried out within 2 h of preparation. Subcellular fractions were obtained from an approx. 25% (w/v) homogenate of liver in sucrose medium (0.25 moll1 sucrose containing 0.1 mmol/l disodium EGTA and 10 mmol/l Tris, adjusted to pH 7.4 with HCI). The pellet from an initial centrifugation at 850 g for 10 rnin was resuspended in sucrose medium to the original value of homogenate and the centrifugation repeated. The combined supernatants from the two centrifugations were then centrifuged at 10 OOO g for 20 rnin in the 3 x 30 ml aluminium swing-out rotor of a Christ Omega I1 ultracentrifuge. The supernatant was decanted and centrifuged at 100 OOO g for 60 min in the 8 x 12 ml titanium angle-head rotor. The 10 000 g and 100 000 g pellets were re-suspended in small volumes of sucrose medium.
Measurement of uroporphyrinogen decarboxylase
5-Carboxyl porphyrinogen solution [0.02 ml, prepared by adding the supernatant from the sodium amalgam reduction to an equal volume of potassium phosphate buffer (100 mmol/l), pH 6.8, containing disodium EDTA (0.1 mmol/l) and sodium thioglycollate (0.1 mol/l)] was added to a 90 mm x 15 mm glass test tube containing liver homogenate (0.2 ml), potassium phosphate buffer, pH 6.8 (80 .umol), sodium thioglycollate (3.2 pmol) and disodium EDTA (0.8 pmol) in a total volume of 1-0 ml. Each tube was kept cold in an ice-bath, was flushed with N t before and during the addition of porphyrinogen solution, and was sealed with a rubber seal as the N z line was withdrawn immediately after the addition of porphyrinogen. Incubation was at 37°C in the dark, with shaking at 20 cycles/min. The reaction was stopped by adding 5.0 ml of ethyl acetatelacetic acid (3 :1, v/v), and mixing. Control tubes in which the reaction was stopped immediately before incubation showed no detectable product formation at 4°C during the time taken to set up twenty tubes (3-5 min).
The tubes were left in the light, but screened from direct sunlight, for 30 rnin to allow complete oxidation of porphyrinogens to porphyrins. After centrifugation, the supernatant was transferred to a 150 mm x 17 mm glass-stoppered tube. The protein precipitate was extracted with a further 3.0 ml of ethyl acetatelacetic acid and thisextract was added to the first supernatant. The pooled extracts were mixed with ether (5.0 ml) and shaken with successive 2.0 ml aliquots of HCl (1.4 mol/l) until all porphyrin was extracted. Usually two extractions were sufficient. The volume of the combined acid extracts was measured and the porphyrin content determined by spectrophotometry. The porphyrins in the acid extract were transferred to ether (2.0 ml) by adding saturated aqueous sodium acetate (0.5 ml/volume of acid used for extraction) and mixing on a Whirlmixer for 10 s. The ether phase was transferred to a clean tube and evaporated in a stream of N 2 at 40°C. The residue was esterified by adding 4.0 ml of methanol/ H2SOs (9:1, vlv) and leaving the mixture at room temperature for 20 h in the dark. Porphyrin methyl esters were recovered by adding chloroform (2.0 ml) to the esterification mixture, mixing, adding water (about 10 ml), mixing, and discarding the aqueous phase, which contained no porphyrin. The chloroform solution was washed once with aq. NH3 soh. (2 mol/l; 3-5 ml), once with water (3-5 ml), transferred to a dry test tube and evaporated in a stream of N2 at 50°C to leave a dry residue.
When uroporphyrinogen 111 was used as substrate, the reaction was stopped in the same way, but the ethyl acetate was then evaporated directly from the mixture in a stream of N2 at 40°C to leave an aqueous, proteinaceous residue which was dried in Z~U O over KOH before being suspended in methanol /H2S04 (9:1, v/v) for 72 h at room temperature in the dark. After centrifugation, porphyrin esters were isolated from the supernatant as described above.
The porphyrin methyl esters obtained from the incubation mixtures were analysed by high-pressureliquid chromatography. Each sample was dissolved in 5-10 pl of chloroform and injected into a highpressure-liquid chromatograph, consisting of a Waters 6000 M pump, columns of 3.2 mm 0.d. (2 mm i.d.), 316 stainless steel, and a Cecil 272 spectrophotometric detector with a 10 p1 flow-cell, monitoring at 400 nm. Three different chromatographic systems, all of which gave similar separations, were used: a 6 ft column of Corasil 11, eluted with 45% ethyl acetate/light petroleum (boiling range 60-80°C); a 2 ft column of Merckosorb SI 60, eluted with ethyl acetate/cyclohexane (40:60); a 3 ft column of Corasil 11, eluted with ethyl acetate/cyclohexane. Porphyrin esters were identified by comparison of retention times with those of a standard mixture of porphyrin methyl esters which was separated at the start of each batch of analyses. The molar ratio of the porphyrin methyl esters in each sample was determined from the areas under the peaks in the chromatogram using a trace, cut and weight procedure. Mixtures containing known quantities of 5-carboxyl porphyrin and coproporphyrin methyl esters were used for calibration. The coefficient of variation for this determination was *2% for five replicate analyses. The quantity of coproporphyrin methyl ester present in each sample, expressed as a percentage of the combined amount of coproporphyrin and 5-carboxyl porphyrin methyl esters, was calculated from the molar ratios. If it is assumed that reduction of 5-carboxyl porphyrin to porphyrinogen is complete and that no preferential loss of either 5-carboxyl porphyrinogen orcoproporphyrinogen, or of the corresponding porphyrins, occurs during the assay procedure, this figure is the percentage conversion of 5-carboxyl porphyrinogen into coproporphyrinogen and can be used to calculate enzyme activity as nmol of coproporphyrinogen formedlmin.
Measurement of urinary nnrl hepatic porphyrin concentrations
Urine (24 h collection) was acidified with acetic acid (0.5 ml) and shaken with butan-1-01 (2.0 ml). The aqueous phase was discarded, ether (8.0 ml) was added and, after mixing, the solution was shaken with repeated small volumes of HCI (1.4 mol/l) until extraction was complete. The volume of the combined acid extracts was measured and the porphyrin content determined spectrophotometrically. Individual porphyrins in urine were measured as described previously (Elder, 1972) . Liver porphyrin concentrations were determined by the method of Abbritti & De Matteis (1971-72) .
Other methods
Porphyrins were decarboxylated by heating in air at 150°C for 120 min . The concentrations of porphyrins in solution were determined spectrophotometrically, from E mmol given by Dowdle, Goldswain, Spong & Eales (1970) and Falk (1964) . The non-haem iron concentration of liver was measured in sucrose (250 mmol/l) homogenates (25%, w/v) as described by Bruckman & Zondek (1940) . Protein was determined (Lowry, Rosebrough, Farr & Randall, 1951) with bovine serum albumin used as standard.
Statistics values was assessed by Student's t-test.
The significance of the difference between mean
Results
Measurement of uroporphyrinogen decarboxylase in homogenates of normal rat liver
The total amount of porphyrin recovered in the acid phase before extraction into ether, expressed as a percentage of the amount of porphyrinogen added and assuming complete reduction of porphyrin to porphyrinogen, ranged from 68 to 75%. The recovery varied little between batches and was independent of substrate concentration (5-25 pmol/l) and of the ratio of 5-carboxyl porphyrin to coproporphyrin. Recoveries were unaltered by replacing homogenate with buffer or by using heatinactivated homogenate in the incubation mixture. These results show that reduction of porphyrin to porphyrinogen was reproducible from experiment to experiment and suggest that preferential loss either of substrate or product did not occur up to this stage of the procedure.
High-pressure-liquid chromatography of the methyl esters isolated from the incubation mixtures showed two peaks with the same retention times as the methyl esters of 5-carboxyl porphyrin and coproporphyrin. No protoporphyrin or 3-carboxyl porphyrin methyl esters were detected, indicating that the oxygen-dependent enzyme, coproporphyrinogen oxidase (EC 1.3.3.3) was effectively inhibited by gassing the tubes with Nz.
At substrate concentrations of 12-15 pmol/l production of coproporphyrinogen was linear with time for at least 20 min and with protein concentration from 0.7 to 6.8 mg (4-40 mg of liver wet wt.).
The reaction rate was independent of substrate concentration from 5 to 50 pmol/l and was not altered by varying the thioglycollate concentration from 1.0 to 4.3 mmol/l. Activity was abolished by heating the homogenate at 90°C for 2 min.
The activity of uroporphyrinogen decarboxylase in liver homogenates from normal female rats was 125 pmol of coproporphyrinogen formed min -mg -of protein (SEM 1.0, n = 12). The coefficient of variation for the method was 12% (calculated from fifty-seven duplicate analyses).
Uroporphyrinogen III and isocoproporphyrinogen as substrates
Under the conditions chosen for the measurement of uroporphyrinogen decarboxylase with 5-carboxyl porphyrinogen as substrate, 7-carboxyl porphyrinogen was the sole detectable product formed from uroporphyrinogen 111 (12 pmol/l). Isocoproporphyrinogen was converted into a 3-carboxyl porphyrinogen identified as 4,6,7-tri(2-carboxyethyl)-2-ethyl-1,3,5,8-tetramethyIhexahydroporphin (i.e. the 2ethyl analogue of harderoporphyrinogen) by mass spectrometry of its porphyrin methyl ester derivative (molecular ion at ni/e 652) and by showing that the corresponding porphyrin was resistant to decarboxylation by a procedure which readily decarboxylated the 5-acetate substituent of isocoproporphyrin.
Location of 5-carboxylporphyrinogen-decarboxylating activity in normal rat liver Table 1 shows that the enzyme which catalyses the formation of coproporphyrinogen from 5-carboxyl porphyrinogen is located in the cytosol fraction of rat liver. The low specific activity of the enzyme in the particulate fractions suggests that the activity in these fractions is due to entrapped cytosol.
Effect of HCB on the decorboxylation of acetatesubstituted porphyrinogens in rat liver
The changes in urinary porphyrin excretion, porphyrin concentration in the liver and the rate of decarboxylation of 5-carboxyl porphyrinogen that occur when a diet containing 0.3% (w/w) HCB is administered to female Wistar rats are shown in Table 2 . The onset of porphyria after a delay of at least 4 weeks is indicated by a marked increase in urinary porphyrin excretion, which is accompanied by accumulation of uroporphyrin and 7-carboxyl porphyrin in the liver. Uroporphyrinogen decarboxylase activity does not alter until the onset of porphyria but as porphyria develops the activity falls progressively to reach 18% of control values by 11 weeks. During this time the excretion of uroporphyrin I11 increases more rapidly than the other urinary porphyrins (Table 3 ). The enzyme from control rats was not inhibited by adding uroporphyrin I11 to the incubation mixture to give concentrations up to 75 pmol/l, indicating that the decrease in activity in HCB-porphyria is unlikely to be due to inhibition by the high concentration of uroporphyrin in the liver.
At 1 1 weeks there was no significant difference between the non-haem iron concentrations, or the total non-haem iron content, of the livers from rats in the control and HCB-treated groups. (Non-haem iron mean concentrations: control, 4.2 pmol/g wet wt., SEM 0.5, n = 4; HCB-treated, 3.6 pmol/g wet wt., SEM 0.3, n = 4; Pz0.3. Non-haem iron mean content: control, 26.7 pmol/liver, SEM 1.1, n = 4; HCB-treated, 35.0 pmol/liver, SEM 2.7, n = 4; P >
0.05.)
The defect in the decarboxylation of acetatesubstituted porphyrinogens in HCB-porphyria is not limited to 5-carboxyl porphyrinogen. Table 4 shows that the rate of decarboxylation of isocoproporphy- rinogen 111 is also markedly decreased. The method described here is unsuitable for the measurement of low activities of uroporphyrinogen decarboxylase in HCB-porphyria if uroporphyrinogen I11 is used as the substrate because large amounts of uroporphyrin and 7-wboxyl porphyrin are present in the liver homogenate, and it is improbable that a decarboxylation rate less than one-third of normal would have been detected. With 5-carboxyl porphyrinogen or isocoproporphyrinogen as substrate low rates of decarboxylation can be measured (Table 4) because the concentrations of the corresponding porphyrins present in the homogenate are too low to interfere with the assay.
Discussion
The method for the measurement of uroporphyrinogen decarboxylase described here is valid only if this is the sole enzyme in rat liver that catalyses the conversion of 5-carboxyl porphyrinogen into coproporphyrinogen. In avian and mammalian erythroid cells uroporphyrinogen decarboxylase is a soluble enzyme, 7-, 6-and 5-carboxyl porphyrinogens accumulate during the course of formation of coproporphyrinogen (Mauzerall & Granick, 1958 ; Cornford, 1964; Tomio et al., 1970) and 5-carboxyl porphyrinogen added to avian erythrocyte haemolysates is metabolized to haem (San Martin de Viale & Grinstein, 1968), coproporphyrin and protoporphyrin (Jackson et al., 1976) . The enzyme from avian erythrocytes has been purified 220-fold and is con-;idered to be a single protein (Tomio et a/., 1970) . Similarly, 7-, 6-and 5-carboxyl porphyrins accumulate during the conversion of uroporphyrinogen into coproporphyrinogen in mammalian liver (San Martin de Viale et al., 1972; Kushner et al., 1975) and the enzyme catalysing this reaction is not sedimented from an isotonic homogenate by centrifugation at 37000 g for 30 min . The enzyme has not yet been purified from mammalian liver. Here we have shown that the cytosol fraction of rat liver contains an enzyme that converts 5-carboxyl porphyrinogen into coproporphyrinogen. At present there is no direct evidence that this enzyme is uroporphyrinogen decarboxylase although studies in other tissues and species suggest that this is likely to be so. The activity of uroporphyrinogen decarboxylase in normal rat liver found with either 5carboxyl porphyrinogen or uroporphyrinogen I11 used as substrate(Tab1es 1,2 and 4) is similar to that reported for the enzyme in human (Kushner & Barbuto, 1974) and pig liver , with uroporphyrinogen I or I11 used as substrate, but is some twenty fold greater than the activity previously reported for rat liver (Taljaard et al., 1971) . Under our assay conditions 7-carboxyl porphyrinogen was the only product formed from uroporphyrinogen 111, and Kushner et al. (1975) have recently shown that this porphyrinogen is a major product of the dewboxylation in vitro of uroporphyrinogen by pig liver uroporphyrinogen decarboxylase. The low activity found by Taljaard et al. (1971) may therefore have been due to their use of an assay method in which products other than coproporphyrin may not be measured. Table 2 shows that there is a close correlation between the development of porphyria due to HCB poisoning and the decrease in the activity of uropor-phyrinogen decarboxylase in the liver. Although the latter was measured with 5-carboxyl porphyrinogen as substrate, measurements made after the onset of porphyria show that the decarboxylation of other acetate-substituted porphyrinogens is also decreased (Table 4) . Furthermore, as the activity of uroporphyrinogen decarboxylase decreases, porphyrins corresponding to the substrate for, and intermediates of, the reaction catalysed by this enzyme become progressively more prominent in the urine (Table 3) . Together, these results suggest that the porphyria is due to the decrease in the activity of this enzyme.
Uroporphyrinogen decarboxylase activity in HCBporphyria
Previously Taljaard Tomio (1976) have reported that the activity of uroporphyrinogen decarboxylase is markedly decreased in the liver in severe HCB-porphyria in the rat. However, the first group found that this defect was present only in animals that were made siderotic before receiving HCB whereas those with HCB-porphyria, but without iron overload, had normal enzyme activities. Although HCB administration may increase liver iron stores (Saunders, Williams & Levey, 1963) this did not occur in our animals. Iron overload accelerates the onset of HCB-porphyria so that although both groups of porphyric animals studied by Taljaard er al. (1971) had received HCB for the same length of time, urinary porphyrin excretion was considerably greater in the iron-overloaded group. Thus the marked decrease in uroporphyrinogen decarboxylase activity in this group is in keeping with our finding that the activity of this enzyme is inversely related to porphyrin excretion (Table 2) . However, normal values were found in the rats with porphyria alone, rather than the smaller decrease in uroporphyrinogen decarboxylase which would be expected from our findings. Joubert, Taljaard & Shanley (1973) emphasized the focal nature of early HCB-porphyria and suggested that the normal enzyme activity might represent the sum of decreased activity in porphyric hepatocytes and compensatorily increased activity in surrounding unaffected cells. Alternatively, the differences between our findings and those of Taljaard et al. (1971) may be related to differences in the sensitivity of the methods employed for the measurement of uroporphyrinogen decarboxylase.
As porphyria develops there is a small increase in the activity of the rate-limiting enzyme of haem synthesis, 8-aminolaevulinate synthase (EC 2.3.1.37) (Rajamanickam, Amrutavalli, Rao & Padmanaban, 1972) . By analogy with other types of experimental porphyria (De Matteis, Abbritti & Gibbs, 1973) , this suggests that the fall in uroporphyrinogen decarboxylase activity initially limits the rate of haem synthesis sufficiently to decrease hepatic haem concentrations. Since haem controls the activity of 8-aminolaevulinate synthase through a negative feedback mechanism this leads to an increase in the activity of this enzyme. The consequent increased production of the initial and intermediate substrates for uroporphyrinogen decarboxylase maintains the rate of coproporphyrinogen formation-and hence haem synthesis-at the required level. Although the administration of HCB produces an immediate and persistent increase in microsomal haemoprotein concentration in the liver (Stonard, 1974) , there is some evidence that by the time porphyria develops the rate of hepatic haem synthesis is normal (Rajamanickam et al., 1972; Taljaard, Shanley, Deppe & Joubert, 1972) . The estimated normal rate of haem synthesis in rat liver, 0.043 nmol min -l g -I wet wt. (Meyer & Marver, 1971) , is well below the lowest enzyme activity found in the present study (0.23 nmol of coproporphyrinogen rnin -' g -' wet wt.).
In HCB-porphyria the liver contains large quantities of uroporphyrin and 7-carboxyl porphyrin (Taljaard et al., 1972), whereas a decrease in uroporphyrinogen decarboxylase would be expected to lead to accumulation of porphyrinogens. Comparison of the rate and pattern of porphyrin excretion, taking both urinary and faecal excretion into account, with the rate and pattern of porphyrin accumulation in the liver shows that the latter represents selective retention of a proportion of the more hydrophilic porphyrins. Thus total porphyrin excretion amounts to some 2000-3000 nmo1/24 h and includes large quantities of 4-, 5-and 6-carboxyl porphyrin, as well as uroporphyrin and 7-carboxyl porphyrin , whereas the maximum combined rate of accumulation of uroporphyrin and 7-carboxyl porphyrin in the liver is approximately 200 nmo1/24 h ( Table 2 ). The porphyrins stored in the liver therefore are not representative of the pattern of overproduction of intermediates in this condition. Clearly storage as porphyrin is compatible with initial accumulation as porphyrinogen followed later by oxidation, a process which may be enhanced in HCB-porphyria by an increase in the N A D + : NADH ratio (Taljaard et al., 1972) .
Large amounts of the isocoproporphyrin group of porphyrins are excreted in the faeces of rats with HCB-porphyria (Elder, 1972; Elder et al., 1976 ) and of patients with symptomatic porphyria (Elder, 1975) . These porphyrins come from dehydroisocoproporphyrinogen, which is produced by the action of coproporphyrinogen oxidase on 5-carboxyl porphyrinogen I11 (G. H. Elder, J. 0. Evans & J. R.
Jackson, unpublished work). The increase in their excretion appears to be due to increased production, secondary to accumulation of 5-carboxyl porphyrinogen, and decreased metabolism, both being consequences of the uroporphyrinogen decarboxylase defect (Table 4) . Excessive excretion therefore indicates a decrease in the activity of uroporphyrinogen decarboxylase relative to that of coproporphyrinogen oxidase; the activity of the latter enzyme is normal in HCB-porphyria . Competition between the two substrates for coproporphyrinogen oxidase, 5-carboxyl porphyrinogen I11 and coproporphyrinogen 111, with a consequent increase in the apparent K,,, of this enzyme for coproporphyrinogen 111, may explain the paradoxical increase in coproporphyrin excretion as the activity of uroporphyrinogen decarboxylase, which produces coproporphyrinogen, falls (Tables 2 and  3) , since the rate of haem synthesis is maintained by the mechanism discussed previously. The manifestations of HCB-porphyria, and presumably the identical porphyrias produced by other polychlorinated hydrocarbons, can therefore all be explained as consequences of the uroporphyrinogen decarboxylase defect. It is probable that the increased excretion of porphyrins with eight to four carboxyl groups, including isocoproporphyrin, and the accumulation of uroporphyrin and 7-carboxyl porphyrin in the liver, which define the syndrome of symptomatic porphyria, similarly indicate an hepatic uroporphyrinogen decarboxylase defect (Kushner & Barbuto, 1974) . However, at present the overproduction of isomer series I porphyrins, which is an important feature of the porphyrinexcretion pattern associated with uroporphyrinogen decarboxylase in man, has not been explained.
The mechanism whereby HCB decreases the activity of uroporphyrinogen decarboxylase is unknown. Our findings and those of San Martin de Wale et al. (1972) indicate that iron overload is not required for this action of HCB. The simplest explanation of our results is that HCB or a metabolite (Sinclair & Granick, 1974; Lui & Sweeney, 1975) acts directly to decrease the activity of the enzyme. If this is SO the delay in onset of the porphyria may represent the time taken to accumulate a toxic dose of HCB.
